Home > Category > Signaling Pathways > Angiogenesis > VEGFR > Alacizumab (Anti-VEGFR2 / KDR / CD309)

Alacizumab (Anti-VEGFR2 / KDR / CD309)

ChemLeader 95+%
Catalog No:CLA1179 CAS No.:934216-54-3 MDLNo: Formula: MW:
Size Availability Price(USD) VIP Price (USD) Quantity
1 mg 3-5days $820.00 Visible after login
- +
5 mg 3-5days $2300.00 Visible after login
- +
10 mg 3-5days $4200.00 Visible after login
- +
50 mg 3-5days $19500.00 Visible after login
- +
100 mg 3-5days $34000.00 Visible after login
- +

Chemical safety data sheet(MSDS)

Download MSDS
  • Product Overview
  • Related documents
  • Product details
  • Related literature
Product Overview
Product Name Alacizumab (Anti-VEGFR2 / KDR / CD309)
CAS934216-54-3
Storage conditionStore at 2 to 8 °C for 1-2 weeks. Store at -20 °C for 12 months. Store at -80 °C for long term storage. Use a manual defrost freezer and avoid repeated freeze-thaw cycles, away from light.
Product details

Alacizumab (Anti-VEGFR2 / KDR / CD309) is a humanized monoclonal antibody targeting VEGFR2 / KDR / CD309 . It has anti-tumour effect in tumour growth. MW :144.08 KD.

Related literature
Sorry, there is no relevant literature
Related
Sorry, no related items
Service
ChemLeader
021-58180488
Online service time: 9:00-18:00 on weekdays